gvtcx

Cancer Vaccines Launch Pad

NHS England Published 29 Feb 2024 Find a Tender

key details

Value£2,100,000
Statuscomplete
Category (CPV) 85100000
Deadline24 Nov 2023
Procedureopen
OCIDocds-h6vhtk-040e7a

Award

SupplierValueDateStatus
UNIVERSITY OF SOUTHAMPTON · · active

description

The CVLP is a strategic priority and collaboration between NHS England, the Department of Health and Social Care (DHSC), the Office for Life Sciences (OLS), the National Institute of Health Research (NIHR) and Genomics England (GEL), with the aim to facilitate access to personalised cancer vaccine research trials. The project was jointly announced in July 2023 with the Secretary of State and in partnership with the Prime Minister. See link (https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials#:~:text=It%20will%20work%20by%20creating,become%20part%20of%20standard%20care)<br/><br/>Through the CVLP platform, cancer patients from across a network of up to 140 NHS cancer care providers will be asked to consent to be put forward for clinical trials. Their surplus tissue samples, obtained through standard of care pathways, will be used to assess their eligibility. The detail of any available trials will be shared with the participant and their treating clinical team to see if the patient wishes to take part, and if so, the patient will travel to the nearest trial site to access the clinical trial.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
24 Oct 2023 Contract notice (F02) Earlier regulations 031301-2023
29 Feb 2024 Contract award notice (F03) Earlier regulations 006588-2024

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.